Pyxis Oncology, Inc. (PYXS) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 71.46M |
| Enterprise Value | 74.72M |
| P/E Ratio | -2.02 |
| PEG Ratio | -0.13 |
| Price/Sales Ratio | 12.12 |
| Price/Book Ratio | 5.38 |
| Enterprise/Revenue | 12.91 |
| Enterprise/EBITDA | -2.36 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -5.9 |
| Operating Margin | -6.2 |
AD
Management Effectiveness
| Return On Assets | -1.27 |
| Return On Equity | -1.36 |
Income Statement
| Revenue | 13.86M |
| Revenue/Share | 0.22 |
| Gross Profit | 11.47M |
| EBITDA | -73.72M |
| Net Income | -79.62M |
| Diluted EPS | -1.28 |
Balance Sheet
| Total Cash | 42.49M |
| Total Cash/Share | 0.67 |
| Total Debt | 18.26M |
| Total Debt/Equity | 0.58 |
| Current Ratio | 2.76 |
| Book Value Per Share | 0.49 |
Price History
| 52-Week Change | 140.91 |
| 52-Week High | 5.55 |
| 52-Week Low | 0.97 |
| Moving Average 50 Days | 2.24 |
| Moving Average 200 Days | 2.34 |
Statistics
| Average Volume | 986,029 |
| Shares Outstanding | 63.36M |
| % Held by Institutions | 43.44 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
